Athenex, Inc. (ATNX)

Trade ATNX now with
6/15/2018 7:04:22 AM Athenex Appoints Benson Tsang To Board Of Directors, Effective July 1
6/14/2018 3:02:04 AM This Day That Year: Athenex
6/4/2018 8:08:57 AM Athenex Names Christina Wang As VP Of Clinical Operations And Corporate Development, Asia Pacific
5/14/2018 7:11:09 AM Athenex Q1 Net Loss $7.3 Mln Vs Net Loss $41.0 Mln Year Ago
4/30/2018 6:31:37 AM Athenex Announces Transition Of James Zukin From Board To An Advisory Role
4/19/2018 8:07:47 AM Athenex Gets FDA Orphan Drug Designation For Oraxol For Angiosarcoma
4/9/2018 8:04:33 AM Cerecor Appoints Simon Pedder To Board Of Directors
3/26/2018 7:17:00 AM Athenex Q4 Net Loss Attributable $28.28 Mln Vs Loss $40.05 Mln Last Year
2/20/2018 8:15:23 AM Athenex Announces Phase II Study Results For KX2-391 Ointment For The Treatment Of Actinic Keratosis
2/15/2018 8:02:47 AM Athenex Meets Enrollment Target For Oraxol Phase III Clinical Trial In Metastatic Breast Cancer
1/25/2018 7:05:21 AM Athenex Announces Pricing Of Offering Of Common Stock
1/22/2018 7:12:21 AM Athenex Announces Encouraging Results Of Phase I Clinical Trial Of Oraxol And CYRAMZ Combination
1/22/2018 7:11:02 AM Athenex Announces Public Offering Of 4.30 Mln Common Shares
1/8/2018 8:32:08 AM Athenex Announces Chinese FDA Allowance Of IND Application Of Oraxol To Begin Clinical Trials
12/27/2017 8:04:22 AM Athenex Receives Promising Innovative Medicine Designation From United Kingdom MHRA For Oraxol
12/15/2017 8:05:39 AM Athenex Initiates Development Of An IND Preparation For Oral Eribulin
12/1/2017 8:06:39 AM Athenex CFO Nick Riehle Retires, Effective December 31